663 Correlation between early endpoints and overall survival in non-small-cell lung cancer: a trial-level meta-analysis

• Faisal Khan,
• Shameer Khader,
• Youyi Zhang,
• Daniel Jackson,
• Kirsty Rhodes,
• Imran Khan Anwer Neelufer,
• Sreenath Nampally,
• Andrzej Prokop,
• Emmette Hutchison,
• Jiabu Ye,
• Feng Liu,
• Antony Sabin,
• James Weatherall,
• Cristina Duran,
• Renee Iacona,
• Pralay Mukhopadhyay

Affiliations

Faisal Khan

1AstraZeneca, Gaithersburg, MD, USA

Shameer Khader

1AstraZeneca, Gaithersburg, MD, USA

Youyi Zhang

1AstraZeneca, Gaithersburg, MD, USA

Daniel Jackson

1AstraZeneca, Gaithersburg, MD, USA

Kirsty Rhodes

1AstraZeneca, Gaithersburg, MD, USA

Imran Khan Anwer Neelufer

1AstraZeneca, Gaithersburg, MD, USA

Sreenath Nampally

1AstraZeneca, Gaithersburg, MD, USA

Andrzej Prokop

2AstraZeneca Pharma Poland, Warsaw, MD, Poland

Emmette Hutchison

1AstraZeneca, Gaithersburg, MD, USA

Jiabu Ye

1AstraZeneca, Gaithersburg, MD, USA

Feng Liu

1AstraZeneca, Gaithersburg, MD, USA

Antony Sabin

1AstraZeneca, Gaithersburg, MD, USA

James Weatherall

1AstraZeneca, Gaithersburg, MD, USA

Cristina Duran

1AstraZeneca, Gaithersburg, MD, USA

Renee Iacona

1AstraZeneca, Gaithersburg, MD, USA

Pralay Mukhopadhyay

1AstraZeneca, Gaithersburg, MD, USA